"10.1371_journal.pone.0035706","plos one","2012-06-29T00:00:00Z","Tomas Kirchhoff; Mia M Gaudet; Antonis C Antoniou; Lesley McGuffog; Manjeet K Humphreys; Alison M Dunning; Stig E Bojesen; B√∏rge G Nordestgaard; Henrik Flyger; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; Thilo Dork; Peter Sch√ºrmann; Johann H Karstens; Peter Hillemanns; Fergus J Couch; Janet Olson; Celine Vachon; Xianshu Wang; Angela Cox; Ian Brock; Graeme Elliott; Malcolm WR Reed; Barbara Burwinkel; Alfons Meindl; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; GENICA Network; Annegien Broeks; Marjanka K Schmidt; Laura J Van ‚Äòt Veer; Linde M Braaf; Nichola Johnson; Olivia Fletcher; Lorna Gibson; Julian Peto; Clare Turnbull; Sheila Seal; Anthony Renwick; Nazneen Rahman; Pei-Ei Wu; Jyh-Cherng Yu; Chia-Ni Hsiung; Chen-Yang Shen; Melissa C Southey; John L Hopper; Fleur Hammet; Thijs Van Dorpe; Anne-Sophie Dieudonne; Sigrid Hatse; Diether Lambrechts; Irene L Andrulis; Natalia Bogdanova; Natalia Antonenkova; Juri I Rogov; Daria Prokofieva; Marina Bermisheva; Elza Khusnutdinova; Christi J van Asperen; Robert AEM Tollenaar; Maartje J Hooning; Peter Devilee; Sara Margolin; Annika Lindblom; Roger L Milne; Jos√© Ignacio Arias; M Pilar Zamora; Javier Ben√≠tez; Gianluca Severi; Laura Baglietto; Graham G Giles; kConFab; AOCS Study Group; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Helene Holland; Sue Healey; Shan Wang-Gohrke; Jenny Chang-Claude; Arto Mannermaa; Veli-Matti Kosma; Jaana Kauppinen; Vesa Kataja; Bjarni A Agnarsson; Maria A Caligo; Andrew K Godwin; Heli Nevanlinna; Tuomas Heikkinen; Zachary Fredericksen; Noralane Lindor; Katherine L Nathanson; Susan M Domchek; SWE-BRCA; Niklas Loman; Per Karlsson; Marie Stenmark Askmalm; Beatrice Melin; Anna von Wachenfeldt; HEBON; Frans B L Hogervorst; Martijn Verheus; Matti A Rookus; Caroline Seynaeve; Rogier A Oldenburg; Marjolijn J Ligtenberg; Margreet GEM Ausems; Cora M Aalfs; Hans JP Gille; Juul T Wijnen; Encarna B G√≥mez Garc√≠a; EMBRACE; Susan Peock; Margaret Cook; Clare T Oliver; Debra Frost; Craig Luccarini; Gabriella Pichert; Rosemarie Davidson; Carol Chu; Diana Eccles; Kai-Ren Ong; Jackie Cook; Fiona Douglas; Shirley Hodgson; D Gareth Evans; Rosalind Eeles; Bert Gold; Paul DP Pharoah; Kenneth Offit; Georgia Chenevix-Trench; Douglas F Easton; on behalf of BCAC/CIMBA","Memorial Sloan-Kettering Cancer Center (MSKCC): Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America (TK, MG, KO); Department of Environmental Medicine, New York University Cancer Institute, New York University, New York, New York, United States of America (TK), American Cancer Society, Atlanta, Georgia, United States of America (MG); Studies of Epidemiology and Risk Factors in Cancer Heredity (SEARCH): Department of Oncology and Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom (ACA, LM, MKH, AMD, PDPP, DFE); The Copenhagen Breast Cancer Study and The Copenhagen General Population Study (CGPS): Department of Clinical Biochemistry (SEB, BGN); Department of Breast Surgery, Herlev Hospital (HF), Copenhagen University Hospital, University of Copenhagen, Denmark; Seoul Breast Cancer Study (SEBCS): Seoul National University College of Medicine and National Cancer Center, Seoul, Korea; Department of Surgery, Ulsan University College of Medicine, Ulsan, Korea (DK, KYY, DYN, SHA); Hannover Breast Cancer Study (HABCS): Clinics of Obstetrics and Gynecology and Clinic of Radiation Oncology, Hannover Medical School, Hannover, Germany (TD, PS, JHK, PH); Mayo Clinic Breast Cancer Study (MCBCS): Mayo Clinic, Rochester, Minnesota, United States of America (FJC, JO, CV, XW); Sheffield Breast Cancer Study (SBCS): Department of Oncology, Sheffield University Medical School, Sheffield, United Kingdom (AC, IB, GE, MWRR); German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC): Institute of Human Genetics, German Cancer Research Center, Heidelberg, Germany (BB); Department of Obstetrics and Gynecology, Division of Tumor Genetics, Technical University of Munich, Munich, Germany (AM); Gene Environment Interaction and Breast Cancer in Germany (GENICA): Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, and University T√ºbingen, Stuttgart and T√ºbingen, Germany (HB, Christina Justenhoven); Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum, Heidelberg, Germany (UH); Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany (YDK,); Institute of Pathology, Medical Faculty of the University of Bonn, Bonn, Germany (Hans-Peter Fischer); Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Bochum, Germany (Thomas Br√ºning, Beate Pesch, Volker Harth, Sylvia Rabstein); Amsterdam Breast Cancer Study (ABCS): Netherlands Cancer Institute, Departments of Experimental Therapy, Epidemiology and Molecular Pathology, Amsterdam, The Netherlands (AB, MKS, LJVV, LMB); British Breast Cancer Study (BBCS): Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (NJ, OF); Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom (LG, JP); ICR Familial Breast Cancer Study (FBCS): Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom (CT, SS, AR, NR); Taiwanese Breast Cancer Study (TWBCS): Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan (CNH, CYS); Taiwan Biobank, Academia Sinica, Taiwan (PEW); Departments of Surgery, Tri-Service General Hospital, Taipei, Taiwan (JCY); Australian Breast Cancer Family Study (ABCFS): Genetic Epidemiology Laboratory, Department of Pathology (MCS, FH), Centre for Molecular Environmental Genetic and Analytic Epidemiology (JLH), The University of Melbourne, Victoria, Australia; Leuven Multidisciplinary Breast Centre (LMBC): Katholieke Universiteit Leuven‚ÄMultidisciplinary Breast Clinic (TVD, ASD, SH), Vesalius Research Center (DL), Leuven, Belgium; Ontario Familial Breast Cancer Registry (OFBCR): Ontario Cancer Genetics Network, Cancer Care Ontario, Ontario, Canada; Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada (ILA); Hannover-Minsk Breast Cancer Study (HMBCS): N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus (NB, NA, JIR); Hannover-Ufa Breast Cancer Study (HUBCS): Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia (DP, MB, EK); Leiden University Medical Center Breast Cancer Study (ORIGO): Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands (MJH); Departments of Surgical Oncology (RAEMT), Clinical Genetics (CJVA), Human Genetics and Pathology (PD), Leiden University Medical Center, Leiden, The Netherlands; Karolinska Breast Cancer Study (KARBAC): Department of Molecular Medicine and Surgery (AL) and Department of Oncology-Pathology, Karolinska Institutet and Karolinska University, Stockholm, Sweden (SM); Spanish National Cancer Center Breast Cancer Study (CNIO-BCS): Genetic and Molecular Epidemiology Group (RLM) and Human Genetics Group (JB), Spanish National Cancer Centre, Madrid, Spain; Centro de Investigaci√≥n Biom√©dica en Red de Enfermedades Raras, Valencia, Spain (JB); Monte Naranco Hospital, Oviedo, Spain (JIA); La Paz University Hospital, Madrid, Spain (MPZ); Melbourne Collaborative Cohort Study (MCCS): Cancer Epidemiology Centre, The Cancer Council, Victoria, Melbourne, Australia and Centre for Molecular Environmental, Genetic, and Analytic Epidemiology, School of Population Health, The University of Melbourne, Australia (GGG, MCS, GS, LB); Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFaB): Queensland Institute of Medical Research, Brisbane, and the Australian Ovarian Cancer Study Group, Peter MacCallum Cancer Center, Melbourne, Australia (ABS, JB, XC, HH, SH, GCT); Genetic Epidemiology Study of Breast Cancer by Age 50 (GESBC): Division of Cancer Epidemiology, German Cancer Research Center [DFKZ], Heidelberg, Germany (JC-C), and Molecular Biology Laboratory, Department of Gynecology and Obstetrics, University of Ulm, Ulm, Germany (SW-G); Kuopio Breast Cancer Project (KBCP): Institute of Clinical Medicine, Department of Pathology, University of Eastern Finland, and Kuopio University Hospital, Biocenter Kuopio, Kuopio Finland (AM, VMK, JK); Department of Oncology, Vaasa Central Hospital, Vaasa, Finland, and Department of Oncology, Kuopio University Hospital, Kuopio, Finland (VK); Iceland Landspitali‚ÄUniversity Hospital (ILUH): Department of Pathology, Landspitali-University Hospital and University of Iceland School of Medicine, Reykjavik, Iceland (BAA); Division of Surgical, Molecular and Ultrastructural Pathology, Department of Oncology University of Pisa and Pisa University Hospital, Pisa, Italy (MAC); Fox Chase Cancer Center (FCCC): Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America (AKG); Helsinki Breast Cancer Study (HEBCS): Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland (HN, TH); Mayo Clinic Familial Breast and Ovarian Cancer Study (MAYO), Mayo Clinic, Rochester, Minnesota, United States of America (FJC, ZF, NL); The University of Pennsylvania (UPENN): Department of Medicine and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America (KLN, SMD); The Swedish BRCA1 and BRCA2 study collaborators (SWE-BRCA): Department of Oncology, Lund University Hospital, Lund, Sweden (NL); Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden (PK); Department of Oncology, University Hospital, Link√∂ping, Sweden (MSA); Department of Radiation Sciences, Oncology, Ume√• University, Ume√• Sweden (BM); Department of Oncology, Karolinska University Hospital, Stockholm, Sweden (AVW); The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON): Coordinating Center: Netherlands Cancer Institute, Amsterdam, The Netherlands (FBLH, MV, MAR); Erasmus Medical Center, Rotterdam, The Netherlands (CS, RAO); Leiden University Medical Center, Leiden, The Netherlands (JTW); Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands (MJL); University Medical Center Utrecht, Utrecht, The Netherlands (MGA); Amsterdam Medical Center, Amsterdam, The Netherlands (CMA); Vrije Universiteit University Medical Center, Amsterdam, The Netherlands (HJPG); University Hospital Maastricht, Maastricht, The Netherlands (EBG); Epidemiological study of BRCA1 and BRCA2 mutation carriers (EMBRACE): Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom (SP, MC, CTO, DF, CL); Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom (DGE); Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom (RE); Clinical Genetics, Guy‚Äôs and St. Thomas‚Äô NHS Foundation Trust, London, United Kingdom (GP); Ferguson-Smith Centre for Clinical Genetics, Yorkhill Hospitals, Glasgow, United Kingdom (RD); Yorkshire Regional Genetics Service, Leeds, United Kingdom (CC); Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom (DE); West Midlands Regional Genetics Service, Birmingham Women‚Äôs Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom (KRO); Sheffield Clinical Genetics Service, Sheffield Children‚Äôs Hospital, Sheffield, United Kingdom (JC); Institute of Human Genetics, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle Upon Tyne, United Kingdom (FD); Clinical Genetics Department, St Georges Hospital, University of London, London, United Kingdom (SH); National Cancer Institute (NCI): Clinical Genetics Branch, National Cancer Institute, Rockville, Maryland, United States of America (BG)","Conceived and designed the experiments: TK MMG BG KO. Performed the experiments: TK MKH ACA MKH LM AMD SEB BGN HF DK K-YY D-YN S-HA TD NB NA JIR FJC JO CV XW AC IB GE MWRR BB AM PS JHK PH HB UH Y-DK AB MKS LJVV LMBNJ OF LG JP CT SS AR NR P-EW J-CY C-NH C-YS MCS JLH FH TVD A-SD SH DL ILA DP MB EK CJVA RAEM MJH PD SM AL RLM JIA MPZ JB GS LB GGG ABS JB XC HH SH S-WG JC-C AM V-MK JK VK BAA MAC AKG HN TH ZF NL KLN SMD NL PK MSA BM AVW FBLH MV MAR CS RAO MJL MGEMA CMA HJPG JTW EBGG SP MC CTO DF CL GP RD CC DE K-RO JC FD SH DGE RE PDPP KO GC-T DFE BGN Y-DK. Analyzed the data: TK MMG. Contributed reagents/materials/analysis tools: KO ACA PDPP GC-T DFE SEB TD HF FJC AC BB AM MWRR HB AB LJVV JP NR CYS DK MCS JLH DL ILA PD AL JB GGG ABS AM JCC BAA MAC AKG HN KLN SMD AVW MAR SH DGE RE. Wrote the paper: TK MMG KO. Collected samples and genotype data for the study, and provided critical review of the manuscript: TK MKH ACA LM AMD SEB BGN HF DK K-YY D-YN S-HA TD NB NA JIR FJC JO CV XW AC IB GE MWRR BB AM PS JHK PH HB UH Y-DK AB MKS LJVV LMB NR OF LG JP CT SS AR NR P-EW J-CY C-NH C-YS MCS JLH FH TVD A-SD SH DL ILA DP MB EK CJVA RAEM MJH PD SM AL RLM JIA MPZ JB GS LB GGG ABS JB XC HH SH S-WG JC-C AM V-MK JK VK BAA MAC AKG HN TH ZF NL KLN SMD NL PK MSA BM AVW FBLH MV MAR CS RAO MJL MGEMA CMA HJPG JTW EBGG SP MC CTO DF CL GP RD CC DE K-RO JC FD SH DGE RE PDPP KO GC-T DFE.","The authors have declared that no competing interests exist.","2012","06","Tomas Kirchhoff","TK",136,FALSE,4,121,2,3,TRUE,TRUE,TRUE,2,"36;75",TRUE
